CGAS and neoplasm: By releasing damage-associated molecular patterns (DAMPs) and activating the cGAS–STING pathway, OVs can remodel the immunologically “cold” tumor microenvironment (TME) into an inflamed and immune-responsive phenotype, thereby enhancing CD8+ T-cell infiltration and improving antitumor immunity.